Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Johnson and Johnson
Chinese Patent Office
Cipla
Argus Health

Generated: September 18, 2019

DrugPatentWatch Database Preview

ZINBRYTA Drug Profile

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Tradename: ZINBRYTA

US Patents for ZINBRYTA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial UNIVERSITY OF WYOMING (Laramie, WY) 2036-03-11 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial Pathologica LLC (San Francisco, CA) 2033-01-08 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial AiCuris GmbH & Co. KG (Wuppertal, DE) 2028-05-08 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial CureVac AG (Tubingen, DE) 2032-02-15 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27   Try a Free Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) 2038-11-23 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for ZINBRYTA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122016000100 Germany   Try a Free Trial PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
PA2015031 Lithuania   Try a Free Trial PRODUCT NAME: TRASTUZUMABAS IR REKOMBINANTINE ZMOGAUS HIALURONIDAZE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
CA 2016 00058 Denmark   Try a Free Trial PRODUCT NAME: DACLIZUMAB; REG. NO/DATE: EU/1/16/1107 20160705
CA 2015 00043 Denmark   Try a Free Trial PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826
300822 Netherlands   Try a Free Trial PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
CR 2014 00008 Denmark   Try a Free Trial PRODUCT NAME: OCLACITINIB, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, F.EKS. MALEATSALTET; REG. NO/DATE: EU/2/13/154/001-006 20130916
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Covington
Farmers Insurance
Julphar
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.